We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current LIPO market cap is 11.79M. The company's latest EPS is USD -1.1228 and P/E is -2.35.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 146k | 136k | 81k | 173k | 129k |
| Operating Income | -1.22M | -952k | -1.46M | -1.45M | -1.33M |
| Net Income | -1.19M | -938k | -1.44M | -1.44M | -1.31M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 962k | 259k | 184k | 450k | 536k |
| Operating Income | -57k | -1.92M | -2.59M | -4.75M | -5.08M |
| Net Income | -62k | -1.87M | -2.6M | -4.62M | -5.02M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 3.14M | 2.18M | 2.16M | 2.67M | 4.86M |
| Total Liabilities | 576k | 480k | 701k | 755k | 777k |
| Total Equity | 2.56M | 1.7M | 1.46M | 1.92M | 4.08M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 955k | 2.01M | 5.95M | 3.58M | 2.67M |
| Total Liabilities | 492k | 589k | 1.27M | 433k | 755k |
| Total Equity | 463k | 1.42M | 4.68M | 3.14M | 1.92M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.39M | -2.31M | -2.96M | -3.95M | -1.43M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 200k | 200k | 1.02M | 2.84M | 3.47M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -28k | -989k | -1.83M | -3.15M | -3.95M |
| Investing | N/A | -301k | 301k | -14k | N/A |
| Financing | 609k | 2.1M | 5.24M | 1.34M | 2.84M |
| Market Cap | 11.79M |
| Price to Earnings Ratio | -2.35 |
| Price to Sales Ratio | 22 |
| Price to Cash Ratio | 5.4 |
| Price to Book Ratio | 6.15 |
| Dividend Yield | - |
| Shares Outstanding | 4.47M |
| Average Volume (1 week) | 20.87k |
| Average Volume (1 Month) | 39.41k |
| 52 Week Change | -49.23% |
| 52 Week High | 12.00 |
| 52 Week Low | 1.965 |
| Spread (Intraday) | 0.8 (26.67%) |
| Company Name | Lipella Pharmaceuticals Inc |
| Address |
108 west 13th street wilmington, delaware 19801 |
| Website | https://www.lipella.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
